Sana Biotechnology, Inc. short interest in 2024
In 2024, Sana Biotechnology, Inc.'s disclosed short interest ran from 10.23% of shares outstanding on 12 Jan 2024 to 16.62% on 31 Dec 2024, a change of +6.39 percentage points. The year's high was 16.62% on 31 Dec 2024 and its low 10.23% on 12 Jan 2024, averaging 13.28% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 39.01 days on 31 Oct 2024. Full history: Sana Biotechnology, Inc..
Cite this page
By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2024 in figures
- Start of year
- 10.23% (12 Jan 2024)
- End of year
- 16.62% (31 Dec 2024)
- Change
- +6.39 pp
- High
- 16.62% (31 Dec 2024)
- Low
- 10.23% (12 Jan 2024)
- Average
- 13.28%
- Highest days to cover
- 39.01 (31 Oct 2024)
- SEC filings marked
- 9
Every report in 2024
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2024 | 10.23% | 1.91 | |
| 31 Jan 2024 | 10.87% | 10.24 | |
| 15 Feb 2024 | 11.20% | 8.12 | results (8-K) |
| 29 Feb 2024 | 10.68% | 8.30 | 10-K filed, results (8-K) |
| 15 Mar 2024 | 12.52% | 10.23 | |
| 28 Mar 2024 | 13.26% | 20.37 | |
| 15 Apr 2024 | 13.56% | 22.11 | |
| 30 Apr 2024 | 13.01% | 14.67 | |
| 15 May 2024 | 11.51% | 10.87 | 10-Q filed, results (8-K) |
| 31 May 2024 | 11.30% | 19.18 | |
| 14 Jun 2024 | 11.02% | 14.58 | |
| 28 Jun 2024 | 11.74% | 9.02 | |
| 15 Jul 2024 | 12.59% | 21.04 | |
| 31 Jul 2024 | 13.40% | 15.93 | |
| 15 Aug 2024 | 14.25% | 21.10 | 10-Q filed, results (8-K) |
| 30 Aug 2024 | 14.30% | 22.84 | |
| 13 Sep 2024 | 14.01% | 23.06 | |
| 30 Sep 2024 | 14.17% | 17.90 | |
| 15 Oct 2024 | 14.96% | 30.30 | |
| 31 Oct 2024 | 15.36% | 39.01 | |
| 15 Nov 2024 | 15.84% | 17.90 | 10-Q filed, results (8-K) |
| 29 Nov 2024 | 15.74% | 21.07 | |
| 13 Dec 2024 | 16.49% | 18.64 | |
| 31 Dec 2024 | 16.62% | 17.55 |
See also: Sana Biotechnology, Inc.'s full history · most shorted US stocks of 2024 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.